ORBIMED ADVISORS LLC 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 7:13 pm Purchase | 2025-05-09 | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 15,252,867 14.500% | 496,771 (+3.37%) | Filing |
| 2024-11-12 5:23 pm Unchanged | 2024-11-07 | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 14,756,096 15.600% | 0 (Unchanged) | Filing |
| 2024-01-25 4:25 pm Purchase | 2024-01-23 | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 14,756,096 17.300% | 454,545 (+3.18%) | Filing |
| 2022-09-16 4:23 pm Purchase | 2022-09-16 | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 14,301,551 23.300% | 11,258,787 (+370.02%) | Filing |